Ohio Third Frontier
6
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
33.3%
2 terminated/withdrawn out of 6 trials
0.0%
-86.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT
Role: collaborator
Assessing Environmental Factors in Healthcare Facilities in Order to Improve the Experience of Patients, Staff, and the Quality of Imaging Procedures
Role: collaborator
Exploring New and Next Generation Ultrasound Technologies for Medical Education, Patient Care, and New Indications
Role: collaborator
Feasibility Assessment of Next-generation PET Technology and Procedures
Role: collaborator
Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
Role: collaborator
Cryotherapy Following Rotator Cuff Repair Surgery
Role: collaborator
All 6 trials loaded